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1. Introduction 
The accurate translation of the genetic information encoded by mRNA into proteins is critical 
for proper cellular function. Transfer ribonucleic acids (tRNAs) are essential biomolecular 
linkers that help maintain translational fidelity by accurately connecting genotype (mRNA) to 
phenotype (protein) during protein synthesis.  The initial stages of ribosomal protein synthesis 
are controlled by aminoacyl-tRNA synthetases (AARSs).  AARSs initiate protein synthesis by 
catalyzing the acylation of tRNAs to their cognate amino acids. The resulting aminoacyl-
tRNAs (aa-tRNAs) are transported to the ribosome by the translation factor Elongation Factor 
(EF-Tu) to undergo peptide bond formation. The synergistic interplay among the protein 
translational machinery involved in this process is highly regulated and extremely accurate. In 
E. coli, the error rate for protein synthesis correlates to roughly 1 misincorporation per 104 
codons translated (Husaain et al., 2006; Loftield & Vanderjagt, 1972; Ogle & Ramakrishnan, 
2005; Rosenberger & Foskett, 1981; Roy & Ibba, 2006).  The high level of stringency is the result 
of substrate discrimination that can occur at four different translation checkpoints:  1) amino 
acid activation, 2) aminoacylation, 3) aa-tRNA transport to the ribosome (via EF-Tu) and 4) 
initial binding of aa-tRNAs within the ribosome. The molecular recognition events mediated 
by AARSs in checkpoints 1 and 2 provide the highest level of stringency.  In vitro studies have 
shown that AARSs possess a discrimination factor of 200 – 10,000 during amino acid 
activation; the stringency factor increases to > 10,000 during aminoacylation (Giege et al., 1998; 
Ling et al., 2009; Reynolds et al., 2010). EF-Tu binding interactions provide an additional, albeit 
lower, degree of stringency in step 3.  Reports show that EF-Tu binds cognate aa-tRNAs with 
nearly identical affinities, while noncognate or misaclyated aa-tRNAs possess extremely broad 
EF-Tu binding affinity profiles (~ 700-fold difference between noncognate aa-tRNAs) (Dale & 
Uhlenbeck; 2005).  It is presumed that these species are removed from the translation pathway 
by EF-Tu to further enhance fidelity. Despite the large amount of studies focused on defining 
the intricacies of translation, there are still a number of unanswered questions regarding the 
basic tenants of translation.  Two intriguing questions are:  i) do tRNAs play an active or passive 
role in the regulation of translation and ii) why is ribosomal protein synthesis limited to 20 amino acids?  
An interrelated question that we would like to address is:  can in vitro binding assays be used to 
accurately define the mechanisms of cellular protein synthesis?  This chapter focuses on current and 
the development of two in vitro binding assays that are designed to investigate the role of 
tRNA in the initial and intermediate stages of translation.  The new assays offer rapid, 
sensitive and straightforward techniques to monitor the role of tRNA in: activation, 
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aminoacylation and aminoacyl transport. A more detailed view of the role of tRNA in 
ribosomal protein synthesis could provide invaluable insight into the evolutionary role of 
tRNA in protein synthesis. Moreover, this information could prove essential in the 
development/ adaptation of in vitro bacterial translation systems to synthesize novel 
biomolecules (i.e. peptidomimetics). 
2. The adaptor hypothesis 
The characterization of tRNA has been a focal point of chemical biology since first postulated 
by Francis Crick in the Adaptor hypothesis in the late 1950s (Crick, 1958).  According to Crick, 
accurate protein synthesis required:  i) a nucleic acid template, ii) an adaptor molecule that 
carried an amino acid to the template and iii) an organized binding arrangement between the 
template and the adaptor.  Research would later reveal the template as mRNA and the adaptor 
as tRNA – while the organized binding interactions correlate to hydrogen-bonds between the 
codon and the anticodon of each species.  Crick’s hypothesis went further to accurately predict 
the existence (and editing capability) of AARSs.  Although certain aspects of the Adaptor 
Hypothesis related to AARS functionality were disproven (i.e. a single AARS is not solely 
dedicated to the aminoacylation of an individual tRNA) (Martin et al., 1977; Wilcox & 
Nirenber, 1968; White & Bayley, 1972) the ideas put forth by Crick helped enable a more 
accurate conceptualization protein synthesis. The Adaptor Hypothesis also laid the 
groundwork for establishing and ultimately deciphering the genetic code. 
2.1 Protein translation 
tRNAs enter the protein synthesis pathway during the second stage of protein synthesis 
(Figure 1).  tRNAs are acylated or “charged”  with amino acids by AARSs and the resulting 
aa-tRNAs are transported to the ribosome by EF-Tu (step 3). The final stages of protein 
translation are initiated in step 4 as each aa-tRNA undergoes initial binding to mRNA 
within the A-site of the ribosomal 50S large subunit.  The remaining translation factors EF-
Ts and EF-G are responsible for the reactivation of EF-Tu and movement (or translocation) 
of each aa-tRNA along the mRNA template.  Finally, ribosomal release factors (RFs1–3 and 
RRF) mediate the termination and release of the protein from the ribosome. After 
completing one round of synthesis, the translational machinery (i.e. tRNAs, AARSs and 
translation factors) is free to re-enter the synthesis pathway to generate new proteins.  Each 
translational component is critical but tRNA is extremely important because it is involved in 
nearly every stage of protein synthesis. 
 
 
Fig. 1. Schematic of E. coli ribosomal protein synthesis. 
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2.1.1 Characterization of transfer ribonucleic acids (tRNAs) 
Zamecnick and Hoagland achieved one of the first major breakthroughs toward the 
discovery of tRNA in 1957. Their work showed that a radiolabelled amino acid becomes 
covalently attached to a “soluble RNA” species (later reclassified as tRNA) when incubated 
with ATP and cellular extracts (Hoagland et al., 1957).  In the following year Zachau et al., 
demonstrated that an ester bond (between a nucleic acid 3’ adenine and 14C-Lue) provided 
the attachment site (Zachau et al., 1958). Robert Holley and his colleagues reached another 
major milestone in 1965 by successfully determining the complete sequence of tRNAAla from 
yeast (Holley et al., 1965). These achievements helped confirm the existence of tRNA as the 
adaptor molecule proposed by Crick and have ushered in a series of discoveries devoted to 
the characterization of tRNAs. 
2.1.2 Structural features of tRNAs 
tRNAs may be most well known for their cloverleaf-like shape. Figure 2a displays the 
cloverleaf structure embedded within a precursor tRNA. Prior to translation, E. coli 
precursor tRNAs undergo enzymatic cleavage reactions at their 5’ and 3’ ends.  5’-end 
processing is carried out by the endonuclease RNase P (Frank & Pace, 1998), while 
3’processing is mediated by a variety of endo- and exonucleases (Morl & Marchfelder, 2001).  
The exact sequence of events and identity of the nucleases involved in 3’ processing are still 
undetermined.  Once fully processed, the resulting tRNA is composed of the five canonical 
structural regions labelled in Figure 2b; clockwise from the 3’ end is the:  acceptor stem, T-
arm, variable loop, anti-codon loop and D-arm. 
The acceptor stem and the anticodon loop are arguably, the most well known of the five 
structural regions (Figure 2b).  The acceptor stem encompasses both ends of the molecule, 
including the -CCA terminal sequence.  The –CCA sequence is encoded in all E. coli tRNAs 
genes and serves as the site of attachment for amino acids.  Aminoacylation does not occur if 
the integrity of the –CCA terminal sequence is not intact.  In the event of mutations or 
damage to the 3’ end, the tRNA maturation/ repair enzyme tRNA nucleotidyltransferase 
(TNT) is upregulated.  In eukaryotes, TNT is responsible for 3’ end maturation by accurately 
synthesizing the final three nucleotides (–CCA) in a template independent fashion 
(Deutscher, 1982; Sprinzl & Cramer, 1979; Yue et al., 1996). TNT carries out a similar task in 
E. coli if the –CCA end is altered (Zhu & Deutscher, 1987). The anticodon loop is located on 
the opposite end of the molecule. The anticodon loop is composed of 7 nucleotides, 
including the anticodon triplet. The first nucleotide of the anticodon can deviate from 
Watson-Crick hydrogen-bond patterns. This phenomenon known as “wobble”  facilitates the 
degeneracy of the genetic code by permitting mRNA codons to bind multiple tRNA 
anticodons. 
The identity and composition of tRNA bases are also very intriguing.  tRNAs contain a 
number of highly conserved bases within the arms (T- and D-) and the anticodon loop 
(labelled white in Figure 2c).  Conserved bases serve a variety of functions ranging from 
maintaining structural integrity to providing favourable contact sites for AARSs and EF-Tu 
during aminoacylation and aa-tRNA transport. A number of tRNA bases also possess 
additional or nonstandard functional groups (i.e. thiol and methyl groups).  This class of 
nucleotides is referred to as “hyper-modified” .  To date > 100 tRNA hyper-modified bases 
have been characterized, with some such as pseudouridine possessing strong evolutionary 
conservation (Dunin-Horkawicz et al., 2006; Iwata-Reuyl, 2008; Rozenski et al., 1999).  These 
structural and chemical characteristics indicate that tRNAs are highly conserved 
biomolecules that are equipped with an appreciable amount of chemical diversity. 
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Fig. 2. tRNA structures before and after 5’ and 3’ end processing.  Panel a) displays 
precursor tRNA.  Panel b) displays the acceptor stem and anticodon loop regions.  Panel c) 
displays the five canonical tRNA secondary structural elements including the T-arm, 
variable loop and D-arm.  Bases indicated in panel c):  A = adenosine, G = guanine, C = 
cytosine, U = uracil, Pu = purine, Py = pyrimidine and ψ = pseudouridine. 
2.1.3 Aminoacylation of tRNAs 
Aminoacylation is initiated by AARSs.  AARSs are highly specific enzymes that bind their 
cognate amino acid in the presence of ATP and transfer the innermost phosphate from ATP 
to the amino acid.  This process is referred to as “activation” because the resulting adenylate 
species, AA-AMP, is highly energetic.  AA-AMPs remains tightly associated with their 
AARS until the AARS•AA-AMP complex encounters a tRNA molecule.  At this stage 
translational fidelity is based on the interplay between the AARS and the tRNA, in that only 
cognate (correct) tRNAs are acylated at a much higher level than noncognate tRNAs.  Figure 
3 displays a schematic of activation (step i) and aminoacylation (step ii). 
 
 
Fig. 3. Schematic of the translational machinery that mediate the early stages of ribosomal 
protein synthesis:  step i) amino acid activation and step ii) aminoacylation. 
A more detailed view of each reaction is shown in Figure 4. During activation, the AARS 
binds the amino acid and orients the α-carboxylate of the amino acid toward the α-
phosphate of ATP.  This alignment promotes an in-line nucleophilic displacement reaction 
as shown in panel a.  The resulting adenylate (AA-AMP) remains bound to the AARS until 
it encounters a tRNA molecule (panel b). The incoming tRNA binds the AARS, which 
subsequently aligns the AA-AMP and tRNA. Next, the 2’ or 3’ hydroxyl of the tRNA 
initiates acylation via nucleophilic attack on the α-carboxylate of the amino acid adenylate 
as shown in panel c.  Finally, the aa-tRNA is generated, AMP is released and the AARS is 
free to catalyze new activation and aminoacylation reactions. 
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Fig. 4. Graphical representation of activation (b) and aminoacylation (d). 
3. Importance of in vitro tRNA aminoacylation assays 
Activation and aminoacylation are closely linked; in fact these steps are often depicted as a 
single reaction.  Although both reactions occur at a rapid rate, it is important to understand 
the mechanistic details of both separately in order to determine the influence that each has 
on translational fidelity. The section of this chapter will focus on the latter, aminoacylation.  
In vitro aminoacylation assays are advantageous because this reaction format enables the 
user to measure both the rate and the level of aminoacylation.  While in vivo assays, despite 
being the physiological benchmark for translation, only provide data that reflects the level 
of aminoacylation.  Despite a large amount of research using both assay formats, there are 
several examples of conflicting results between in vitro and in vivo experiments. It is not 
surprising that in vivo and in vitro data generate conflicting results since proteins are the 
product of a biological paradox.  In that, native proteins (i.e. full-length proteins without 
mutations or truncations etc.) possess an enormous level of accuracy despite being 
manufactured over a short period of time. Developing in vitro and in vivo assays that 
accurately define how the two seemingly opposing forces of: translational speed and 
translational accuracy coexist is a very complicated task.  This point is more clearly shown by 
the discrepancies that exist between in vivo and in vitro experiments designed to determine 
the effect that the G3•U70 tRNAAla recognition element on aminoacylation.  In vitro assays 
showed that mutations within the recognition element drastically reduced aminoacylation 
(Beuning et al, 1997; Frankyln & Schimmel, 1989; Hou & Schimmel, 1988; McClain et al., 
1988; Musier-Forsyth et al., 1991).  While in vivo experiments indicated that mutations within 
the recognition element had a minimal effect (Gabriel et al., 1996; McClain et al., 1999).  
Despite advancements in in vitro and in vivo assays, a number of discrepancies between the 
two formats remain.  This section will focus on current and new assays designed to provide 
a more clear view of aminoacyaltion. 
3.1 In vitro aminoacylation assays using radioactive amino acids 
The most predominately used in vitro aminoacylation assay is based on the techniques 
developed by Zamecnick et al. using 14C labelled amino acids (Hoagland et al, 1957). The assay 
measures the rate of formation of radiolabelled aa-tRNAs under steady state conditions. The 
reaction is initiated by titrating a labelled amino acid into a reaction vessel containing the 
cognate AARS, tRNA and ATP (complete buffer composition detailed in Figure 6). 
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Fig. 5. Schematic of L-alanine illustrating the potential isotopic labelling sites for 14C (red) 
and 3H (grey). 
Aminoacylation is recorded by: i) removing aliquots at different time points, ii) spotting 
each aliquot onto pre-soaked nitrocellulose filters [soaked with tricholoroacetic acid (TCA)], 
iii) washing each filter with excess TCA and 95% ethanol.  Finally, each filter is dried and 
placed into a scintillation vial. The amount of 14C or 3H precipitated onto the filter is 
recorded using a scintillation counter.  The major steps of this reaction are displayed below 
in Figure 6. 
 
 
Fig. 6. Diagram of common method to measure aminoacylation using radioactive amino 
acid substrates.  Reaction buffer:  50 mM HEPES (or Tris-HCl) pH 7.5, 2 mM ATP, 10 mM 
MgCl2, 4 mM DTT, 20 mM KCl, bovine serum albumin (0.2 mg/ mL).  Nitrocellulose 
membranes pre-soaked in excess TCA to ensure the maximum level of precipitation. 
The level of aminoacylation is determined indirectly by first calculating the amount 
radiolabelled amino acid that is bound to a filter (at time x) (Eigner & Loftield, 1974; 
Loftield, 1974). The amount of precipitated amino acid is determined from the specific 
activity of the amino acid and the scintillation counting efficiency. The level of 
aminoacylation is determined by dividing the amount of labelled aminoacyl tRNA (bound 
to the filter) by the total input tRNA. Although this assay is widely used, there are 
significant drawbacks associated with it. One major limitation is related to the indirect 
nature of the readout. The assay does not stringently distinguish active (acylated) from 
inactive (non-acylated) tRNAs. This is a large potential source of error that could lead to 
incorrect aminoacylation values. Other limitations are related to the use of 14C and 3H 
labelled amino acids.  Radiolabelled amino acids are generally limited to the 20 L-amino 
acids. Hence, the analysis of unnatural (non-L) amino acids is prohibited. Also large 
amounts of substrate are required due to the low affinity AARS have toward their cognate 
amino acid (KM values range of µM to mM) (Eriani et al., 1993; Hill & Schimmel, 1989; Ibba 
et al., 1996). To offset the accompanying high levels of radioactivity, extremely high 
amounts of tRNA must be supplied or the concentration of the amino acid must be reduced 
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to levels that are below saturating conditions. The latter set of conditions (i.e. reducing 
amino acid concentrations) prohibits the use of this assay to monitor pre-steady state 
kinetics because the specific activity of each radioisotope is too low to generate a reliable 
signal. Based on these issues, there is clearly a need to develop alternate methods to 
measure aminoacylation. 
3.2 In vitro aminoacylation assays using radioactive tRNAs 
3.2.1 Aminoacylation of nicked 32P labelled tRNAs 
One technique that has emerged as an alternative to the radiolabelled amino acid assay is 
based upon on using 32P-labeled tRNAs. This approach, pioneered by the Uhlenbeck 
laboratory offers a number of advantages vs. the classical aminoacylation assay. Their initial 
strategy employed 32P-labeled “nicked” tRNAs as substrates (Wolfson et al, 1998). The tRNA 
was prepared by annealing a longer unlabelled ribonucleic strand to a shorter 32P-labeled 
strand.  The longer strand (57-nt) encompassed the majority of the tRNA (5’ acceptor region, 
D-arm, anticodon, variable loop and part of the T-arm); while the shorter strand (19-nt) 
encompassed a portion of the T-arm and acceptor stem.  The longer strand was generated 
via in vitro transcription using T7 RNA polymerase. The shorter strand was generated via 
standard chemical synthesis and subsequently labelled with 32P-γ-ATP using T4 
polynucleotide kinase (T4PNK). A schematic of the resulting tRNA is shown in Figure 7b, 
the position of the radiolabel within the T-arm is denoted with an arrow. 
 
 
Fig. 7. Schematic of intact (a) vs. nicked (b) tRNAs.  The in vitro transcribed strand is shown 
in black and the chemically synthesized strand is shown in grey. 
To initiate the assay, radiolabelled tRNA is incubated with an amino acid and AARS of 
interest. The reaction is then quenched and loaded onto an acid denaturing 
polyacrylamide gel.  Since aa-tRNAs possess a relatively larger positive charge than non-
acylated tRNAs, aa-tRNAs migrate slower than the non-acylated tRNAs. The level of 
aminoacylation is measured by dividing the number of counts of the aminoacylated tRNA 
by the number of counts of non-acylated tRNA (counts measured via Phosphorimager 
analysis). The ability to distinguish aa-tRNAs from nonacylated tRNAs in a 
straightforward manner significantly reduces the level of error associated with this assay 
vs. the assay using radiolabelled amino acids. The 32P isotope also provides a much 
stronger signal than 14C and 3H, this feature permits the use of much lower amounts of 
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amino acid. As a result, this assay is capable of measuring aminoacylation at pre- and 
steady state conditions. The expense and variable stability of 14C or 3H amino acids also 
add to the attractiveness of an alternate assay. Finally, the use of 32P labelled tRNAs 
provides a method to measure the aminoacylation of unnatural amino acids.  Despite its 
advantages, the nicked tRNA assay has drawbacks related to safety, compatibility and run 
time. The high-energy 32P isotope requires the use of protective shielding and typical run 
times range from 12-16 h to fully separate the acylated and non-acylated tRNAs. Taken as 
a whole the benefits of this assay outweigh the disadvantages, but there is still room for 
improvement. 
3.2.2 Aminoacylation of full-length 32P labelled tRNAs 
Uhlenbeck et al. improved the nicked tRNA assay by making several key adjustments 
(Wolfson & Uhlenbeck, 2002). The first was related to the positioning of the 32P radiolabel.  
The repair/ processing enzyme terminal nucleotidyl transferase (TNT) was used to label the 
3’-end of the tRNA. TNT labels tRNAs by exchanging the 3’-terminal non-labelled (“cold”) 
adenosine with a 32P-α-adenosine to yield a new 3’ radiolabelled tRNA. This step is 
displayed in Figure 8a; the radiolabelled product is denoted in red. This labelling procedure 
circumvents the two-step process associated with the preparation of nicked tRNAs. The 
aminoacylation reaction is identical to the approach described in section 3.2.1.  The next 
major change involves the use of nuclease P1 or S1 to separate aminoacylated from non-
acylated tRNAs.  Both endonucleases digest aa-tRNAs to yield two products: 32P-AA-AMP 
and 5’ monophosphates.  aa-tRNAs represent the former and nonacylated tRNAs the latter. 
Each radioactive species is separated clearly and rapidly via thin layer chromatography 
(TLC).  This step obviates the lengthy run times associated with acid gel electrophoresis. The 
level of aminoacylation is recorded by dividing the number of counts of the 32P-AA-AMP 
species by the counts of 5’ monophosphates (32P-AMP). Figure 8 displays a schematic of the 
labelling (step a) and hydrolysis of 3’-32P-aa-tRNAs. 
Due to the sensitivity of the 32P isotope, this assay can measure the rate of aminoacylation at 
pre- and steady state conditions. As stated earlier, pre-steady state analysis is essentially not 
feasible with the conventional aminoacylation assay. 
The 32P tRNA assay also provides enhanced user flexibility. As a result, the steady state 
reaction conditions can be altered to more closely resemble in vivo conditions.  Wolfson & 
Uhlenbeck exploited this feature to investigate the discrepancies between in vitro and in 
vivo assays, describing the role of the G3•U70 tRNAAla recognition element (Wolfson & 
Uhlenbeck, 2002). As discussed in section 3, in vitro assays indicated that changes within 
the recognition element significantly reduced the rate of aminoacylation, while in vivo 
experiments showed that mutations within the recognition element produced a minimal 
effect.  Since the reaction conditions of the 32P assay are more amenable to alerations, the 
amounts of inorganic pyrophosphatase (PiPase) and EF-Tu were increased to levels that 
more closely resemble in vivo conditions.  The level and rate of aminoacylation were 
shown to be clearly dependent upon the reaction conditions. Under standard in vitro 
conditions (i.e. reduced levels of PiPase and in the absence of EF-Tu), the rate and the 
level of aminoacylation was strongly affected by the integrity of the G3•U70 tRNAAla 
recognition element.  Mutations within the recognition element showed a significant 
reduction in the both the rate (reduced kcat/ KM) and the level of aminoacylation. Upon 
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increasing the concentration of PiPase and EF-Tu to near in vivo levels, the level of 
aminoacylation showed the opposite effect (a marked increase in aminoacylation). These 
results clearly show the power of this assay.  As a result, the intricacies of aminoacylation 
can be investigated over a wider range of conditions that conventional in vitro and in vivo 
assays cannot. 
 
 
 
 
 
Fig. 8. Panel a) Schematic of the 3’-32P labelling procedure using the repair/ processing 
enzyme terminal nucleotidyl transferase (TNT).  Panel b) displays the hydrolysis products 
following enzymatic digestion with either nuclease S1 or P1. 
The versatility of this assay can also be extended to monitor the aminoacylation of unnatural 
amino acids.  We have used this assay to successfully aminoacylate a variety of natural and 
unnatural amino acids.  As shown in Figure 9, tRNAVal is aminoacylated with L-Val and two 
unnatural amino acids: N-methyl val and α-hydroxy valine. The level of aminoacylation of 
each residue is shown in the accompanying bar graph.  Figure 9b clearly shows that ValRS 
efficiently acylates both L- and N-methyl val, while α-hydroxy val is largely non-acylated.  
Although more detailed analysis is required to determine the exact mechanism(s) of 
discrimination, one can surmise that the reduced level of acylation of α-hydroxy valine is 
the result of the editing domain of ValRS that works in concert with tRNAVal to hydrolyze 
the α-hydroxy residue. 
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Fig. 9. Panel (a) displays the TLC image from a typical aminoacylation reaction of tRNAVal 
with three different amino acids:  L-Val, N-methyl val and α-hydroxy valine with ValRS*.  
Panel (b) bar graph representation of the level of aminoacylation of each amino acid.  *The 
concentration of ValRS (0.5 uM) was optimized/ reduced to ensure the level(s) of 
aminoacylation of N-methyl val and α-hydroxy valine were not contaminated with L-Val.  
Bell et al. unpublished results. 
3.3 Development of a novel aminoacylation assay using 32P labelled amino acids 
We are currently developing a novel assay to measure the level of aminoacylation that 
merges the basic principles of the assays described sections in 3.1 and 3.2.2. In our assay, 32P 
labelled amino acids are used as substrates. 32P labelled amino acids are prepared using a 
modified version of the assay developed in the Perona laboratory (Gruic-Sovulj et al., 2005).  
Amino acids are radiolabelled, by incubating the substrate in the presence of 32P-α-ATP and 
an AARS. The newly formed 32P-labelled amino acid serves as a substrate for 
aminoacylation. This process is shown in Figure 10b. Aminoacylation is again initiated by 
introducing tRNA and the reaction proceeds to yield two species:  acylated tRNA (aa-tRNA) 
and AMP.  32P is highlighted in each step and serves as the readout to measure the level or 
rate of aminoacylation. 
 
 
Fig. 10. Panel a) schematic displaying the formation of the 32P radiolabelled amino acid 
[32P]AA-AMP during activation. Panel b) schematic of the formation of 32P-α-ATP during 
aminoacylation. 
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The readout for aminoacylation is based upon the “release”  of 32P-α-AMP from the activated 
substrate ([32P]AA-AMP) as the 2’  OH of the tRNA attacks the carbonyl group of the 
activated amino acid.  The level of aminoacylation corresponds with the increase in 32P-α-
AMP counts and a decrease in [32P]AA-AMP counts. Each reaction component can be 
separated and quantified via TLC and Phoshorimager analysis. An idealized schematic 
displaying the electrophoretic mobility of an activated amino acid is shown in Figure 11.  
The radiolabelled activated (adenylate) species is denoted with the grey arrow, note there is 
also a measurable amount of AMP present due to spontaneous (albeit lower) hydrolysis of 
the activated species.  The intensity (or number of counts) of the [32P]AA-AMP correlates to 
the relative amount of activated substrate that can undergo aminoacylation. 
 
 
Fig. 11. Schematic of the separation of an activated amino acid generated by incubating an 
amino acid of interest with its cognate AARS. 
In order to initiate the aminoacylation reaction, tRNAs are added in increasing amounts. 
The level of aminoacylation generates a measurable readout when the amounts of tRNA, 
AARS and amino acid approach equivalence. At this point, the level of [32P]AA-AMP 
decreases while 32P-α-AMP increases (as the radiolabelled monophosphate is released).  
Figure 12 displays a schematic of the change in counts of each species during a typical 
aminoacylation reaction. 
We have used this assay to measure the aminoacylation of tRNATyr as shown in Figure 13.  
Eight identical reactions (containing 10 µM L-Tyr and 10 µM TyrRS) were prepared without 
tRNA to ensure an appreciable amount of amino acid was activated.  Next, eight different 
amounts of tRNA was added to each tube and the reaction was incubated for 5 min.  As 
shown in the bar graph the level of aminoacylation (32P-AMP) remains relatively constant until 
the tRNA concentration increases to 0.50 µM (position 6, Figure 13).  At this point, the 32P-AMP 
counts begin to increase significantly.  Aminoacylation is complete at tRNA levels ≥ 5 µM 
(position 8, Figure 13).  Under these conditions, the highest amount of 32P-AMP was released 
as noted by the large increase in 32P-α-AMP counts.  Conversely, the level of activated amino 
acid is completely consumed. 
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Fig. 12. Schematic illustrating separation of each radiolabelled species during a typical 
aminoacylation reaction containing a [32P]AA-AMP substrate.  As the amount of tRNA 
increases the level of aminoacylation increases, this corresponds to the release (and increase 
in the counts) of 32P−α-AMP. 
 
 
Fig. 13. Aminoacylation of 10uM activated L-Tyr with increasing amounts of tRNATyr.  
Reaction conditions:  10.0 µM aaRS, 10 µM AA incubated at 37o C for 2 minutes to permit 
activation.  tRNAs added to separate reaction activation reactions at concentration range of 
0.001 – 5.0 µM.  Each reaction quenched at 5 min in 0.1 U/ µL Nuclease P1.  Reaction buffer 
composition:  30 mM HEPES (pH 7.0), 15 mM MgCl2, 250 mM KCl, 20 mM β-
mercaptoethanol, 2 µM ATP, Inorganic pyrophosphatase (0.2 U/ µL) and 32P α-ATP. 
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This reaction format has a number of advantages.  Like the 32P tRNA assay, the sensitivity 
of the 32P signal should permit the alteration of reaction components to more closely 
resemble in vivo conditions. The assay provides a straightforward and rapid technique to 
measure acylation that does not require labelling of tRNAs.  As a result, this assay could 
be used to rapidly evaluate the selectivity of tRNAs with various AARS/ AA pairs.  In 
that, tRNAs can be rapidly screened with noncognate [32P]AA-AMP substrates to 
determine any potential selectivity embedded within tRNAs toward noncognate amino 
acids.  We have also used this assay to aminoacylate in vitro transcribed tRNAs as well 
(data not shown).  Finally, the aminoacylation of unnatural amino acids can also be 
monitored.  We have evaluated several unnatural amino acids (i.e. 3-fluoro tyr, 3-NO2 tyr 
etc.) using this assay and each analogue displayed a similar aminoacylation trend as 
shown in Figure 13 (data not shown). At this stage, this assay is being used in our 
laboratory primarily as a qualitative tool to monitor the level of aminoacylation but we 
believe that it offers a tremendous level of potential to help elucidate the role of tRNAs in 
aminoacylation. 
4. Importance of in vitro aa-tRNA: EF-Tu binding assays 
As stated earlier, the third step in the protein synthesis pathway is the transport of aa-
tRNAs to the ribosome by the bacterial translation factor EF-Tu.  The process begins 
immediately after aminoacylation as EF-Tu binds aa-tRNAs to form a stable aa-tRNA:EF-
Tu•GTP ternary complex.  X-Ray crystallography data reveals that EF-Tu binds the 
acceptor stem and t-arm of each aa-tRNA (Figure 2) (Nissen et al., 1995; Nissen et al., 
1999) to effectively “protect”  the aminoacyl bond during translation.  At this stage, 
translational fidelity is largely mediated by EF-Tu.  Uhlenbeck et al. have used RNase 
protection assays to elegantly show that EF-Tu binds cognate aa-tRNAs within a narrow 
binding range (LaRiviere et al., 2001; Pleiss & Uhlenbeck, 2001; Dale et al., 2004; Ashara & 
Uhlenbeck, 2005; Sanderson & Uhlenbeck 2007).  Their data shows that EF-Tu binds 
cognate aa-tRNAs with dissociation constant (KD) values that range from 5 – 50 nM (Dale 
& Uhlenbeck; 2005).  It is presumed EF-Tu binds cognate aa-tRNAs with near uniformity 
to deliver these substrates to the ribosome to undergo translation whereas misacylated or 
non-cognate aa-tRNAs are removed from the translational pathway. The narrow binding 
profile that EF-Tu has towards a limited, yet diverse set of substrates presents an 
interesting scenario that can be best described from an evolutionary standpoint.  
Uhlenbeck and others postulate that individual tRNAs and their respective cognate amino 
acid have co-evolved.  As a result, each aa-tRNA has undergone evolutionary fine-tuning 
and EF-Tu binds each cognate aa-tRNA with near uniformity to mediate the next step of 
translation.  The exact mechanism(s) that EF-Tu uses to eliminate misaclyated aa-tRNAs 
are unclear.  Two plausible outcomes are: i) EF-Tu binds misacylated aa-tRNAs with a 
very low affinity (KD >> 50 nM) and as a result AARSs may intervene to 
hydrolyze/ remove the misaclyated amino acid or ii) EF-Tu binds the misacylated aa-
tRNA with an extremely high affinity (KD << 5 nM) that prevents proper loading of the 
aa-tRNA onto the ribosome.  There is also growing evidence that shows EF-Tu works in 
concert with the ribosome during the “ initial binding”  phase to ensure cognate aa-tRNAs 
are translated.  The focus of this chapter, however, will describe the individual binding 
interactions between aa-tRNAs and EF-Tu. 
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4.1 Current in vitro based assays aa-tRNA: EF-Tu binding assays 
RNase protection assays are one of the most prevalent techniques used to measure EF-
Tu:aa-tRNA dissociation constants.  The assay uses a nitrocellulose membrane to isolate aa-
tRNA:EF-Tu ternary complexes that remain intact following hydrolysis with the 
ribonuclease, RNase A.  RNase A is an ideal choice to investigate these binding interactions 
because the enzyme cleaves single stranded RNAs at the 3’ cytosine (and uridine) position.  
RNase A and EF-Tu essentially compete for the same position on the aa-tRNA, with the 
former attempting to degrade the tRNA and latter protecting it. 
To start the analysis, aa-tRNAs are generated using standard aminoacylation procedures 
described in sections 3.1 and 3.2.2.  Next, the labelled aa-tRNAs (3H, 14C or 32P) are purified 
to remove the AARS(s). The ternary complex is formed, by incubating EF-Tu with the 
labelled purified aa-tRNA. The RNase protection assay is capable of measuring EF-Tu 
dissociation constants under either equilibrium or kinetic conditions.  At equilibrium 
conditions, the stability of individual ternary complexes is investigated.  In each case, a set 
amount of aa-tRNA (i.e. 10 nM) is mixed with a range of EF-Tu concentrations (0.1 – 500 
nM) to form a series of ternary complexes.  Each reaction is initiated with the addition of 
RNase A at concentration known to rapidly and completely hydrolyze aa-tRNAs in the 
absence of EF-Tu.  Each reaction is quenched (~20s), placed onto the filter binding apparatus 
that contains a nitrocellulose membrane and washed five times with 5-10% (w/ v) 
trichloroacetic acid (TCA).  This step ensures an appreciable amount of ternary complex is 
precipitated onto the membrane. Next, the membrane is removed, dried and exposed with a 
Phosphorimager screen corresponding to the radiolabel of interest (3H, 14C or 32P).  Finally, 
the number of counts of each reaction (denoted as fraction xx-tRNAXx in Figure 14b) is 
plotted vs. the EF-Tu concentration. The midpoint or region of 50% complex corresponds to 
the KD as shown in the idealized schematic in Figure 14b. 
 
 
Fig. 14. Panel a) schematic of nitrocellulose membrane representing the counts remaining 
following the digestion of aa-tRNA:EF-Tu complex with RNase A under equilibrium 
conditions.  Panel b) schematic of fitting analysis used to derive EF-Tu dissociation constant, 
KD. 
As stated earlier, the RNase protection assay can be used to measure the kinetic properties 
of EF-Tu binding also. In this case, the KD is determined by calculating the rate of hydrolysis 
(koff) of a single ternary complex.  Using this format, a single ternary complex is formed by 
incubating an aa-tRNA (10 nM) with excess EF-Tu (100 or 1 x 103 nM) at 4oC for 30 minutes.  
Next, RNase A is added to initiate the hydrolysis reaction.  During the reaction, aliquots are 
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removed from the reaction vessel and quenched at different time points.  Each aliquot is 
loaded onto the filter binding apparatus and washed with TCA as described previously.  
Next, the counts of each aliquot are measured and the koff is obtained by linear regression 
analysis.  More specifically, the ln of counts at each time point is plotted vs. time (of 
quenching).  The negative slope is equivalent to the koff.  Finally, the KD is obtained by 
dividing the koff by the on-rate constant (kon).  The kon for typical aa-tRNA:EF-Tu complexes 
have been calculated as 105 or 106 M-1min-1 (LaRiviere et al., 2001). 
 
 
Fig. 15. Panel a) schematic of nitrocellulose membrane representing the counts remaining 
following the digestion of aa-tRNA:EF-Tu complex with RNase A under kinetic 
conditions.  Panel b) schematic of linear regression analysis used to derive the off-rate 
constant, koff. 
To date, RNase protection assays could arguably be regarded as the gold standard for 
measuring EF-Tu binding constants. These assays have proven to be a workhouse 
technique that has provided an enormous level of insight toward to underlying 
mechanisms of translation.  However, there are significant disadvantages associated with 
protection assays.  The primary drawback is the large amount of experimental variability 
associated with these assays.  Reports show that these assays can typically generate 
between 20 to 40% variability per analysis. The high level of variance may be related to 
the weak signal strength associated with the 3H and 14C, while 32P despite being more 
sensitive again requires shielding for protection.  These reasons show that despite its 
success there is a need to develop additional assays to investigate the binding properties 
of EF-Tu to aa-tRNAs. 
4.2 Development a novel fluorescent assay to monitor aa-tRNA: EF-Tu binding 
interactions 
We are currently developing a fluorescence based polyacrylamide gel assay as an alternate 
technique to measure EF-Tu:aa-tRNA binding interactions.  A fluorescence-based assay was 
selected because this method offers a reliable and safe method to measure EF-Tu binding 
that would circumvent the drawbacks related to the variability and safety of 14C and 32P 
assays.  The assay follows a similar procedure to those described in section 4.1 with three 
noted exceptions:  i) a fluorophore is conjugated to the tRNA prior to aminoacylation, ii) an 
RNase mixture (RNase A/ T1, Ambion) is used to hydrolyze aa-tRNAs and iii) a native 
PAGE gel is used to separate hydrolyzed aa-tRNAs from the in tact ternary complexes. 
www.intechopen.com
 Biotechnology of Biopolymers 
 
358 
4.2.1 Conjugation of tRNA with fluorescent label 
For our analysis the thiol-reactive Alexa Fluor® 488 C5 maleimide dye was selected to label 
the tRNA. The maleimide functional group provides an ideal molecular handle that can 
undergo a coupling reaction with the thiouridine (s4U) tRNA hyper-modified base.  The 
reaction is non-enzymatic and proceeds to completion in 2 hours at 37oC or in 12-16 hours at 
4oC. The labelled tRNA is separated from non-conjugated dye via 
phenol/ chloroform/ isoamyl extraction or NAP column purification. Figure 16a displays the 
structures of Alexa Fluor 488 C5 maleimide and s4U. The location of s4U within the single 
stranded region connecting the D-arm and acceptor stem is displayed in Figure 16b.  
 
 
 
Fig. 16. Panel a) schematic of Alexa Fluor 488 maleimide and 4-thiouridine functional 
groups.  Panel b) location of the 4-thiouridine hyper-modified base within the secondary 
structure of tRNA. 
4.2.2 Aminoacylation characteristics of fluorescently labelled aa-tRNAs 
Despite the advantages related to safety and ease of conjugation, the presence of a relatively 
large fluorophore near the tRNA acceptor stem could potentially perturb the 
aminoacylation. To address this issue, we have measured the aminoacylation of tRNAs 
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labelled with both 32P and Alexa Fluor 488. Figure 17 displays a TLC image of the 
aminoacylation profile of tRNATyr with L-Tyr and series of unnatural amino acids.  As 
evidenced in the high levels of acylation (> 70%) for L-Tyr (position 1) and 3-fluoro tyr 
(position 3), the presence of the dye does not have a deleterious effect on aminoacylation.  
The reduced level of acylation for the remaining unnatural amino acids (positions 2, 4 and 5) 
is consistent with data using tRNAs labelled solely with 32P (data not shown).  Hence, the 
reduced aminoacylation levels for these samples are presumably the result of editing by 
TyrRS and not the fluorophore. 
 
 
 
Fig. 17. Aminoacylation of dual labelled tRNATyr.  The tRNA is labelled with 32P and Alexa 
Fluor 488.  The level of aminoacylation is recorded based on the technique discussed in 
section 3.2.2.  The resulting aa-tRNAs correspond to tRNATyr acylated with the following 
amino acids in lanes 1 – 5:  L-Tyr(lane 1), 3-nitro tyr (lane2), 3-fluouro tyr (lane 3), N-methyl 
tyr (lane 4) and α-hydroxy tyr (lane 5). 
4.2.3 Hydrolysis of fluorescently labelled aa-tRNAs 
The positioning/ conjugation of the fluorophore to a uridine base within a single stranded 
region of the tRNA is a critical feature of the assay.  As stated earlier, RNase A hydrolyzes 
substrates at cytosine and uridine residues.  Therefore, the fluorescent aa-tRNA should be 
hydrolyzed in a similar fashion as described in section 4.1. To ensure the aa-tRNA 
undergoes complete hydrolysis, we employed an RNase enzyme mixture composed of the 
RNases A and T1. RNase T1 is an exonuclease that cleaves at single stranded guanine 
residues.  We presume that RNase A will provide the driving force to initiate hydrolysis due 
to its relatively higher activity than RNase T1.  A comparison of the hydrolytic activity of the 
RNase A/ T1 mixture vs. RNase III and RNase VI reveal that RNase A/ T1 is the most 
effective (data not shown).  Figure 18 displays the hydrolysis of the fluorescent ValtRNAVal-
488, in the presence of RNase A/ T1.  Lane 1 corresponds to the intact aa-tRNA in the absence 
of the RNase cocktail.  Lanes 2 – 8 correspond to ValtRNAVal-488 hydrolyzed with RNase 
A/ T1 at time points of 5, 10, 15, 20, 25, 30 and 60 seconds. As noted in lanes 2-8, intact 
ValtRNAVal-488 is rapidly hydrolyzed.  The major hydrolyzed species is presumably a longer 
segment(s) of the labelled 5’end; while the faster running species correspond to a 
heterogeneous mixture of hydrolyzed labelled tRNAs. 
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Fig. 18. Polyacrylamide gel analysis of the hydrolysis of labelled ValtRNAVal-488 with the 
RNase cocktail – RNase A/ T1.  Lane 1 corresponds to 5.0µM ValtRNAVal-488 in the absence of 
RNases.  Lanes 2 – 8 correspond to individual ValtRNAVal-488 (5.0µM) samples incubated 
with RNase A/ T1 cocktail (1.25 Units A & 50 Units T1) for 5, 10, 15, 20, 25, 30 and 60 
seconds, respectively.  Each reaction was quenched with unfractionated yeast total tRNA 
(1.0 mg/ mL).   Gel conditions:  15% tris boric acid gel, 1X TBE running buffer (90 mM 
Trisma, 90 mM boric acid and 2 mM EDTA), run time 4 hours at 4oC. 
4.2.4 Evaluation of EF-Tu binding properties to fluorescent aa-tRNAs 
This assay like the filter binding assay described in section 4.1 can be utilized to measure aa-
tRNA:EF-Tu binding constants under equilibrium and kinetic conditions.  Thus far we have 
only investigated the kinetic reaction format.  One critical feature that must be determined is 
the optimum RNase concentration that will permit reliable off rate measurements. The 
RNase concentration used in Figure 18 (1.25 Units RNase A & 50 Units RNase T1) degrades 
the ternary complex too rapidly to reliable measure the kinetics. To address, a series of 
lower RNase concentrations have been used to measure stability of EF-Tu:aa-tRNA ternary 
complexes.  Figure 19 shows the typical hydrolysis profile of ValtRNAVal-488 bound to EF-Tu.  
Panel a) displays the hydrolysis profile of the ternary complex using an RNase cocktail 
concentration composed of 5 x 10-4 and 0.02 units of RNAase A and T1. Panel b) displays the 
hydrolysis profile of the ternary complex using lower amounts of RNases.  In this case, 1 x 
10-4 and 4 x 10-3 units of RNase A and T1 are employed.  As shown below, the second RNase 
concentration is more amenable to measuring EF-Tu binding characteristics since the 
complex is present throughout the duration of the reaction (2 – 120 seconds). 
Using these RNase concentrations as a baseline, the reaction was extended to longer time 
points in order to obtain koff measurements.  As shown in Figure 20 lanes 5 – 9, the complex 
degrades gradually in the presence of the RNase cocktail.  The diminished level of ternary 
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complexes (lanes 5-7) corresponds with an increase in the level of hydrolyzed products.  The 
accompanying graph displays the hydrolysis profile of the reaction.  Although this data is 
unable to be fit via linear regression analysis, it does indicate the ternary complex 
dissociates appreciably with time. 
 
 
Fig. 19. Polyacrylamide gel analysis of the hydrolysis of ValtRNAVal-488:EF-Tu ternary complex 
with RNase A/ T1 cocktail.  Ternary complex composed of ValtRNAVal-488 (0.5 µM) and EF-Tu 
(5.0 µM).  Panel a) RNase A/ T1 cocktail (5 x 10-4 Units A & 0.02 Units T1), panel b) RNase 
A/ T1 cocktail (1 x 10-4 Units A & 4.0 x 10-3 Units T1).  Lane 1 ValtRNAVal-488 (0.5 µM), lane 2 
ValtRNAVal-488:EF-Tu (0.5 µM and 5.0 µM), lanes 3 – 7 corresponds to reaction run times of 2, 5, 
10, 30 and 120 seconds, respectively.   Each reaction was quenched with unfractionated yeast 
total tRNA (1.0 mg/ mL).  Gel conditions:  15% tris boric acid gel, 1X TBE running buffer (90 
mM Trisma, 90 mM boric acid and 2 mM EDTA), run time 4 hours at 4oC. 
 
 
Fig. 20. Polyacrylamide gel analysis of the hydrolysis of ValtRNAVal-488:EF-Tu ternary 
complex with RNase A/ T1 cocktail.  Ternary complex composed of ValtRNAVal-488 (0.5 µM) and EF-
Tu (5.0 µM), RNase A/ T1 cocktail (1 x 10-4 Units A & 4.0 x 10-3 Units T1).  Lane 1 ValtRNAVal-488 (0.5 µM), 
lane 2 ValtRNAVal-488:EF-Tu (0.5 µM and 5.0 µM), lanes 3 – 9 corresponds to reaction run times of 0.3, 0.7, 
1, 1.4, 2, 6 and 8 minutes, respectively.   Each reaction was quenched with unfractionated yeast total 
tRNA (1.0 mg/ mL). Gel conditions:  15% tris boric acid gel, 1X TBE running buffer (90 mM Trisma, 90 
mM boric acid and 2 mM EDTA), run time 4 hours at 4oC. 
The hydrolysis profile is very inconsistent at time points < 40 sec (Figure 20 and additional 
data not shown).  One possible approach to improve the hydrolysis profile may be related to 
the optimization of the RNase composition.  The inconsistent hydrolysis profile may occur 
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since three enzymes are effectively competing for a single aa-tRNA. RNAse T1 is present at 
nearly 50-fold excess to RNase A but despite the large excess of RNase T1 this enzyme is 
much less reactive. As a result, RNase T1 may actually inhibit or reduce the efficacy of 
RNase A at the initial stage(s) of the reaction.  We are currently investigating the hydrolysis 
of ternary complexes using RNase A alone. 
5. Conclusion 
We have presented two new assays that we believe can be used to further elucidate the role 
of tRNA in aminoacylation and aa-tRNA transport. The aminoacylation assay merges 
concepts from established techniques, while offering a novel approach to measure 
aminoacylation. The new assay does not require labelling of tRNAs. Therefore, the 
aminoacylation procedure is more straightforward. The presence of the 32P radioisotope 
provides an extremely sensitive signal.  Therefore, the reaction conditions can be readily 
changed – this feature enables the investigation of aminoacylation under standard in vitro 
and in vivo-like conditions.  The second assay uses fluorescently labelled aa-tRNAs as 
substrates to monitor the stability of aa-tRNA:EF-Tu ternary complexes.  The assay is unique 
in that it uses a fluorophore that is site specifically conjugated to a single-stranded region of 
the tRNA.  The location of the fluorophore within this region is critical for two reasons:  i) 
labels (moieties) located at the 5’ or 3’ terminus could deleteriously affect aminoacylation 
and ii) standard RNases (i.e. RNase A) should generate a predictable hydrolysis profile.  
Despite the ease of use of this system the fluorophore does not supply the same sensitivity 
as provided by 32P.  However, the lack of sensitivity may be offset by the fact that the 
“entire”  reaction volume can be loaded onto a gel and subsequently quantified. 
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